TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ANVS

Annovis Bio Inc

Healthcare · Biotechnology

1.20$ +0.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ANVS
Line item 2009 2010 2011 2012 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% – 100.0% – – – – – – – – –
34.2% 84.2% – 6.2% – – – – – – – – –
65.8% 15.8% – 93.8% – – – – – – – – –
2,286.9% 33.8% – 1,051.9% – – – – – – – – –
2,358.0% 118.0% – 1,058.1% – – – – – – – – –
-2,258.0% -18.0% – -958.1% – – – – – – – – –
0.0% 0.0% – 0.0% – – – – – – – – –
-2,351.5% -17.5% – -914.8% – – – – – – – – –
0.0% 0.8% – 0.0% – – – – – – – – –
-2,351.5% -18.3% – -4,495.6% – – – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?